Opening book details…
About this Medicine article
TRICC-C: Nintedanib vs. placebo in patients receiving mFOLFOX6 for metastatic, chemorefractory colorectal cancer: Final results from the randomized phase II trial of the AIO by Ettrich, T J; Berger, A W; Decker, T; Hofheinz, R D; Heinemann, V; Hoffmann, T; Hebart, H F; Herrmann, T; Hannig, C-V; Büchner-Steudel, P; Bartholomäus, H; Güthle, M; Perkhofer, L; Seufferlein, T is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Ettrich, T J; Berger, A W; Decker, T; Hofheinz, R D; Heinemann, V; Hoffmann, T; Hebart, H F; Herrmann, T; Hannig, C-V; Büchner-Steudel, P; Bartholomäus, H; Güthle, M; Perkhofer, L; Seufferlein, T
- Publisher
- Oxford University Press; Elsevier BV (ISSN 0923-7534)
- Published
- 2018
- Field
- Medicine (Health Sciences)